@melasphinx Profile picture

MELASPHINX

@melasphinx

Research team at the Cancer Research Center of Toulouse (France) on ceramide metabolism in melanoma: from basic mechanisms to the clinic.

Similar User
CRCT-Oncopole photo

@crctoncopole

Pierre Cordelier photo

@CordelierPierre

Martinet Ludovic photo

@MartinetLudovi2

Benoît Thibault photo

@BenoitThibault_

Sarry Lab photo

@jeansarry

Colacios Céline photo

@ColaciosC

Guillermet's Lab photo

@GuillermetLab

Gilles Favre photo

@GillesFavrecrct

Cancéropôle GSO photo

@CanceropoleGSO

Marie Sorbara photo

@MarieSorbara

Fondation Toulouse Cancer Santé photo

@ToulouseCancer

Nicolas Bery photo

@BeryNicolas

La Ligue contre le Cancer de Haute-Garonne photo

@Liguevscancer31

CRCT postdoc photo

@Crct_Postdoc

Olivier Calvayrac photo

@ocalvayrac

MELASPHINX Reposted

Programmation génétique : les travaux de recherche de Sylvain Cussat-Blanc de @IRIToulouse et Salvatore Valitutti @ValituttiLab du @crctoncopole récompensés par le prestigieux prix Humies Awards. ➡️ut-capitole.fr/accueil/recher…

Tweet Image 1

MELASPHINX Reposted

The program of the 13th ICC and 2025 FEBS Special Meeting on Sphingolipid Biology: Breaking Boundaries will cover a range of fundamental and cutting-edge topics in sphingolipid-related research! You can find more information (and register) through here sphingolipidbiology2025.febsevents.org/programme-feat…


MELASPHINX Reposted
Tweet Image 1

Our new paper on #ceramide #metabolism in #melanoma #dedifferentiation upon #TNF: from basic mechanisms to the clinic in patients treated with #immune #checkpoint #inhibitors. #Sphingolipids as new #biomarkers to predict resistance. @crctoncopole @IUCTOncopole @CareGraduate

New Research: Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients frontiersin.org/articles/10.33… #FrontiersIn #Immunology



MELASPHINX Reposted

🇬🇧[CRCT Publication] Human genetic defects of sphingolipid synthesis. Review of @melasphinx team's in @JIMD_Editors march 2024. ➡️crct-inserm.fr/defauts-geneti

Tweet Image 1

Excellente expérience pour Victoria et Nouhaila, élèves du secondaire (collège Jules Vallès à Portet sur Garonne, et lycée Pierre de Fermat à Toulouse), encadrées par Benjamin Jung et Tania Margarido Pereira dans le cadre des apprentis chercheurs au @crctoncopole

[4/8] les apprentis chercheurs (APC) du CRCT en vidéo saison 2.@crctoncopole,@ArbreDC Présentation des apprentis chercheurs de l'équipe MELASPHINX @melasphinx lors du congrès des APC le 28 juin 2023. ➡️youtu.be/YQJzZayIrkY

Tweet Image 1


Great talk by Ira Mellman from @genentech at the @crctoncopole . An honour and pleasure to talk to Ira.

Amazing to have the legend Ira Mellman @genentech in Toulouse! Very inspiring seminar focussing on the importance of the TME, couldn't agree more!



MELASPHINX Reposted

🇫🇷 Étude de la contribution de lipides tumoraux dans l’évolution métastatique d’un mélanome cutané. Publié dans @CellReports 12/2023 par l'équipe @melasphinx du @crctoncopole . #oncométabolisme, #lipides, #Cancer , #peau, #ingénierietissulaire ➡️crct-inserm.fr/etude-de-la-co…

Tweet Image 1

MELASPHINX Reposted

🇬🇧Study of the contribution of tumour lipids to the metastatic progression of cutaneous melanoma. Published in @CellReports 12/2023 by @melasphinx teams from @crctoncopole . #oncometabolism, #lipides, #Cancer , #skin, #Tissueengineering ➡️crct-inserm.fr/en/study-of-th…

Tweet Image 1

MELASPHINX Reposted

FEBS special meeting on Sphingolipid Biology just started. The auditorium is full. Thank you everyone for coming! And special thanks to all our sponsors to make this event happen! @FEBSnews @sanofi @CaymanChemical @Lipotype_Global @EMBOevents @FEBS_Letters @FEBSOpenBio

Tweet Image 1
Tweet Image 2
Tweet Image 3

#Postdoctoral fellow at the #Cancer Research Center, Toulouse, France on the impact of combining #TNF blockade and #immunotherapy on #immune responses and #melanoma liver metastases in #mice. 2 year contract from Nov 1, 2023 Contact bruno.segui@inserm.fr before October 15, 2023.


Perfect organisation for the summer school on medicine in Barcelona. Happy to have contributed to this program together with @CordelierPierre and @PoupotRemy A special thanks to @pastorangladamarcal @CareGraduate @crctoncopole @IUCTOncopole

Tweet Image 1

MELASPHINX Reposted

Summer school on medicines 13 faculty, super hero style, today at Barcelona supercomputing center. Amazing visit !

Tweet Image 1

Very impressive indeed

@CareGraduate⁩ in BSC today during SSM13 in Barcelona ⁦@crctoncopole

Tweet Image 1


Nice program, looking forward to joining you tomorrow evening. @CareGraduate @crctoncopole @IUCTOncopole

Summer school on Medecines starts today in beautiful Barcelona

Tweet Image 1


Congratulations Pierre!

All my gratitude to the @fondationarc for their support. With this "équipe labélisée" grant, We will explore the potential of #oncolyticvirus for the therapy of #PancreaticCancer @crctoncopole

Tweet Image 1


Very happy and proud to have contributed to this ceremony with a speech in the honour of Dr Tatiana Vidaurre Rojas, expert on #breastcancer in Peru.

The UT3 nominated Pr. Tatiana Vidaurre Rojas, from the Cayetano Heredia Peruvian University, as Doctor Honoris Causa. Since 2022, a Memorandum of Understanding links the Master’s program on medical oncology that she leads with the CARe Graduate School. bit.ly/3pqfpPX

Tweet Image 1


Congratulations to all. Looking forward to welcoming you on the PhD program of CARe.

Marcelo HURTADO, Laura JOUVIN, Ram Kumar PARI, Raphael DE ARAUJO BEAUVILAIN ALVES DE SOUZA and Roxane SYLVESTRE will receive a doctoral grant to conduct their PhD in CARe’s partner laboratories. We wish them every success! bit.ly/3qD5S8u



MELASPHINX Reposted

Melasphinx team is proud of Mathieu Virazels (PhD student) for his poster #eacrImmunoOncology #melanoma #Immunotherapy #tnf @crctoncopole @IUCTOncopole @melasphinx @CareGraduate

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.